Bilcare Limited posted its results for the quarter ended September 30, 2010. The India standalone net sales for the second quarter ended September 30, 2010 stood at Rs.160.62 crores as against Rs.135.32 crores in the same quarter of the previous year, showing a growth of 19%. This resulted in higher EBITDA of Rs.48.38 crores from Rs.39.06 crores in the corresponding quarter of the previous year, showing a growth of 24%. Pursuant to a definitive agreement dated August 2, 2010, Bilcare AG, a wholly owned step down subsidiary of the Company has acquired the INEOS Films business, through a merger process in Germany, with operations spread across Germany, Italy, US and India for a consideration of EUR 96 million against the networth of the acquired business of EUR 98 million. Accordingly, INEOS Films business has become a part of the Company with effect from September 1, 2010. The overseas business of the company continued to show robust growth achieving net sales of Rs.305.37 crores (which includes Rs.144 crores from the INEOS Films business for the month of September 2010) in the second quarter of the current year from Rs.127.96 crores in corresponding quarter of the previous year, resulting a growth of 139%. The EBITDA from overseas business grew by 123% from Rs.23.33 crores in Q2FY2010 to Rs.52.05 crores in Q2FY2011. The consolidated net sales for the quarter ended September 30, 2010, thus stood at Rs.465.99 crores, showing a growth of 77% over the corresponding quarter of the previous year; with the consolidated EBITDA increasing to Rs.100.43 crores from Rs.62.39 crores of the corresponding quarter of the previous year, a growth of 61%. Net profit for the said quarter stood at Rs.46.53 crores as against Rs.27.85 crores in the corresponding quarter of the previous year, showing a growth of 67%. The consolidated net sales for the half year ended September 30, 2010 stood at Rs.774.53 crores as against Rs.501.75 crores in the same period of the previous year. This resulted in the EBIDTA of Rs.176.88 crores in H1FY2011 up from Rs.118.16 crores of H1FY2010, a growth of 50%. Net profit for the period ended September 30, 2010 stood at Rs.77.20 crores as against Rs.50.69 crores in the same period of the previous year, resulting in a growth of 52% About Bilcare : Bilcare Research (Bilcare) is a unique organization with a strong research foundation and an unending quest for global leadership. Bilcare offers customer-centric innovation for pharmaceutical packaging, card solutions, specialty film solutions and clinical trial supplies management. Through nonClonableID™ technology, Bilcare offers path breaking business solutions in brand protection and business intelligence. Bilcare operates best in class manufacturing and research facilities in Germany, India, Italy, Singapore, UK and USA. An organization made up of motivated people who go that extra mile to spread excellence and joy. Press Contact: Jaydip Chowdhury Head Corporate Communications Bilcare Research 601 -ICC Tower ,Pune Phone: 020 30257787 Email: Jaydip.Chowdhury@Bilcare.com